Dr. Christoph Huber, Chief Scientific Officer, Anaveon AG, Technologiepark Basel, Basel, Switzerland

Development of an engineered IL-2 cytokine for the treatment of cancer

Start Date 02.06.2021 - 17:15
Event End 02.06.2021 - 18:15
Location Departement Pharmazeutische Wissenschaften
Zoom
Website

Seminars on Drug Sciences (SDS)

All seminars on Drug Sciences this semester will be online via Zoom.
Link for lecture with Manuela Rogalski () till Wednesdays 11:30 a.m.